Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report)’s stock price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.88 and traded as high as $1.84. Mesoblast shares last traded at $1.84, with a volume of 5,246 shares.
Mesoblast Stock Performance
The business has a 50-day moving average of $1.17 and a two-hundred day moving average of $0.89.
About Mesoblast
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.
Read More
- Five stocks we like better than Mesoblast
- Market Cap Calculator: How to Calculate Market Cap
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
- What Does a Stock Split Mean?
- Top 3 ETFs to Hedge Against Inflation in 2025
- 3 Healthcare Dividend Stocks to Buy
- These 3 Chip Stock Kings Are Still Buys for 2025
Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.
